Mainichi.jp: June 12, 2012. Researchers at a hospital in Kobe have found a way to treat stroke victims using white blood cells from their bone-marrow fluid, in what could emerge as a new treatment method lessening the burden on patients. In clinical tests at the Institute of Biomedical Research and Innovation Hospital in Kobe, researchers […]
Circ.ahajournals.org: June 12, 2012. Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased risks of stroke, heart failure, dementia, and death.1–8 Because the number of elderly individuals will increase over the years to come, the prevalence of AF is predicted to increase dramatically.9Symptoms are a major reason that patients with AF seek medical […]
Sciencedirect.com: June 7, 2012. Atrial fibrillation is now recognized as a significant medical and social problem. Atrial fibrillation not only causes cardiovascular complications, including thromboembolism and heart failure, but also decreases the survival of patients with impaired left ventricular function; thus, it is considered an independent factor for cardiovascular death. The goal of antiarrhythmic drug therapy […]
Frontiersin.com: June 7th, 2012. The aim of this study was to investigate initiation of and persistence with warfarin treatment in patients with atrial fibrillation according to ethnicity. Patients hospitalized with first-time atrial fibrillation from 1997-2009, prescription claims of warfarin and country of birth were identified by individual-level linkage of nationwide administrative agencies. Cox proportional hazards models […]
Dovepress.com: June 1, 2012. Warfarin, the most commonly used antithrombotic agent for stroke prophylaxis in atrial fibrillation (AF), requires regular monitoring, frequent dosage adjustments, and dietary restrictions. Clinicians’ perceptions of barriers to optimal AF management are an important factor in treatment. Anticoagulation management for AF is overseen by both cardiology and internal medicine (IM) practices. Thus, […]
Nature.com: April 29, 2012 Atrial fibrillation is a highly prevalent arrhythmia and a major risk factor for stroke, heart failure and death1. We conducted a genome-wide association study (GWAS) in individuals of European ancestry, including 6,707 with and 52,426 without atrial fibrillation. Six new atrial fibrillation susceptibility loci were identified and replicated in an additional […]
Bmj.com: May 31, 2012. Objective To model the long term effectiveness and cost effectiveness of daily dark chocolate consumption in a population with metabolic syndrome at high risk of cardiovascular disease. Design Best case scenario analysis using a Markov model. Setting Australian Diabetes, Obesity and Lifestyle study. Participants 2013 people with hypertension who met the criteria for metabolic syndrome, with […]
Plosone.org: May 30, 2012. Individuals differ in the response to regular exercise. Whether there are people who experience adverse changes in cardiovascular and diabetes risk factors has never been addressed. Methodology/Principal Findings An adverse response is defined as an exercise-induced change that worsens a risk factor beyond measurement error and expected day-to-day variation. Sixty subjects were […]
Journals.lww.com: May 10, 2012 Background: Cardiovascular disease is increased among HIV-infected patients, but little is known regarding ischemic stroke rates. We sought to compare stroke rates and determine stroke risk factors in HIV versus non-HIV patients. Methods: An HIV cohort and matched non-HIV comparator cohort seen between 1996 and 2009 were identified from a Boston health […]
Stroke.ahajournals.org: May 1, 2012. Background and Purpose—Data from randomized trials assert that asymptomatic patients undergoing carotid endarterectomy (CEA) must live 3 to 5 years to realize the benefit of surgery. We examined how commonly CEA is performed among asymptomatic patients with limited life expectancy. Methods—Within the American College of Surgeons National Quality Improvement Project we identified […]
